Narrow search
Showing 1 - 10 of 31,224
Cover Image
Advances in Cancer Therapeutics and Patient Access to New Drugs
Dranitsaris, George; Truter, Ilse; Lubbe, Martie S.; … - In: PharmacoEconomics 29 (2011) 3, pp. 213-224
Globally, there are approximately 7.4 million cancer deaths annually, approximately 13% of deaths from all causes …. Cancer is a disease of older people and, as the population ages over the next 10-20 years, we can expect an increase in the … cancer incidence. Encouragingly, cancer mortality has stabilized in many countries. Part of this success may be attributed to …
Persistent link: https://www.econbiz.de/10010614407
Cover Image
Cost Effectiveness of Preventive Screening Programmes for Type 2 Diabetes Mellitus in Germany
Schaufler, Thilo M.; Wolff, Malte - In: Applied Health Economics and Health Policy 8 (2010) 3, pp. 191-202
healthcare costs as well as the challenges caused by a double-aging society. The early detection and prevention of chronic … symptoms). Prevention strategies after diagnosis of pre-diabetes encompassed lifestyle and metformin interventions. Methods … prevention with metformin [year 2006 values]) and even cost saving in the subgroup diagnosed with pre-diabetes and …
Persistent link: https://www.econbiz.de/10008620559
Cover Image
Measuring the Externality of Antibacterial Use from Promoting Antimicrobial Resistance
Kaier, Klaus; Frank, Uwe - In: PharmacoEconomics 28 (2010) 12, pp. 1123-1128
prioritizing prevention methods. …
Persistent link: https://www.econbiz.de/10008725817
Cover Image
Influenza Vaccination in Healthy Working Adults in Russia: Observational Study of Effectiveness and Return on Investment for the Employer
At'kov, O. Yu. Atkov; Azarov, A.V.; Zhukov, D.A.; … - In: Applied Health Economics and Health Policy 9 (2011) 2, pp. 89-99
Background: All age groups are affected by influenza infection, resulting in significant medical and economic burden. Influenza infection of healthy working adults can have a marked effect on companies due to lost work days and reduced productivity. Studies in corporate settings have shown that...
Persistent link: https://www.econbiz.de/10010614270
Cover Image
Cost Effectiveness of Pneumococcal Conjugate Vaccination against Acute Otitis Media in Children: A Review
Boonacker, Chantal W.B.; Broos, Pieter H.; Sanders, … - In: PharmacoEconomics 29 (2011) 3, pp. 199-211
While pneumococcal conjugate vaccines have shown to be highly effective against invasive pneumococcal disease, their potential effectiveness against acute otitis media (AOM) might become a major economic driver for implementing these vaccines in national immunization programmes. However, the...
Persistent link: https://www.econbiz.de/10010614297
Cover Image
Rotavirus Vaccine RIX4414 (Rotarix™): A Pharmacoeconomic Review of its Use in the Prevention of Rotavirus Gastroenteritis in Developing Countries
Plosker, Greg L. - In: PharmacoEconomics 29 (2011) 11, pp. 989-1009
This article provides an overview of the clinical profile of rotavirus vaccine RIX4414 (Rotarix™) in the prevention of …
Persistent link: https://www.econbiz.de/10010614303
Cover Image
The Authors' Reply
Kapoor, Alok; Radhakrishnan, Nila; Smith, Kenneth J. - In: PharmacoEconomics 28 (2010) 9, pp. 782-784
Persistent link: https://www.econbiz.de/10010614307
Cover Image
The Authors' Reply
McCullagh, Laura; Tilson, Lesley; Walsh, Cathal; Barry, … - In: PharmacoEconomics 28 (2010) 9, pp. 784-785
Persistent link: https://www.econbiz.de/10010614318
Cover Image
Posaconazole: A Pharmacoeconomic Review of its Use in the Prophylaxis of Invasive Fungal Disease in Immunocompromised Hosts
Lyseng-Williamson, Katherine A. - In: PharmacoEconomics 29 (2011) 3, pp. 251-268
Posaconazole (Noxafil) is an oral, second-generation, extended-spectrum triazole whose approved indications include prophylaxis of invasive fungal disease (IFD) in immunocompromised patients. In pivotal head-to-head trials, posaconazole was significantly more effective in preventing IFD than...
Persistent link: https://www.econbiz.de/10010614335
Cover Image
Cost Effectiveness of Venous Thromboembolism Pharmacological Prophylaxis in Total Hip and Knee Replacement:: A Systematic Review
Plumb, Jonathan M.; Clemens, Andreas; Monz, Brigitta U. - In: PharmacoEconomics 28 (2010) 9, pp. 781-782
Persistent link: https://www.econbiz.de/10010614396